Want to join the conversation?
$GOOG $GOOGL said OpEx was $7.4Bil in 2Q16, and OpEx rose YoverY driven by R&D expense mainly due to compensation expense related to headcount growth. Headcount at the end of 2Q16 was 66,575, up 2,460 sequentially & the vast majority of new hires continue to be engineers & product managers to support growth in priority areas such as cloud and apps.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.